Vaxcyte PCVX
NASDAQ PCVX
$56.05 -0.85 (-1.49%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Net Equity Issued and Repurchased (2019 - 2026)

Updated

Vaxcyte (PCVX) reported Net Equity Issued and Repurchased of $7.76 million for Q2 2026, up 139.9% from $3.24 million a year earlier but down 14.1% from the prior quarter.

Analysis

Vaxcyte (PCVX) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vaxcyte's Net Equity Issued and Repurchased came in at $20.51 million, down 24.0% year-over-year; for FY2025, it was $13.01 million, down 52.1% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -34.7% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $27.14 million in FY2024 (+255.0%), $7.65 million in FY2023 (-92.1%), $97.3 million in FY2022 (+600.2%) and $13.9 million in FY2021 (-87.4%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of -$83.14 million in Q4 2023 and a high of $49 million in Q2 2022.
  • Year over year, Net Equity Issued and Repurchased gained in three of the last seven quarters, with an average decline of 4.7%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q3 2022 (growth of 600.6%); the low point was Q3 2025 (a decline of 97.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $9.03 million (Q1 2026), $3.42 million (Q4 2025) and $306,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Vaxcyte 8.24 Bn 8.24 Bn - 7.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.76 Mn
Mar 31, 2026 9.03 Mn
Dec 31, 2025 3.42 Mn
Sep 30, 2025 306,000.00
Jun 30, 2025 3.24 Mn
Mar 31, 2025 6.05 Mn
Dec 31, 2024 5.98 Mn
Sep 30, 2024 11.74 Mn
Jun 30, 2024 4.40 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 -83.14 Mn
Sep 30, 2023 49.00 Mn
Mar 31, 2023 41.79 Mn
Dec 31, 2022 2.06 Mn
Sep 30, 2022 43.12 Mn
Jun 30, 2022 49.00 Mn
Mar 31, 2022 3.12 Mn
Dec 31, 2021 6.79 Mn
Sep 30, 2021 6.16 Mn
Jun 30, 2021 466,000.00
API Access

Vaxcyte Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PCVX&period=max&api_key=YOUR_API_KEY